PATENT COUNSELING & STRATEGIC ADVICE

From the largest domestic or international corporation or university to the individual inventor or entrepreneur, we are committed to handling your patent matters with both scientific and legal excellence.

  • Assisted in litigation regarding paragraph IV certification and whether a generic drug is entitled to 180-day exclusivity.
  • Negotiated with FDA and U.S. Customs to remove import detentions on medical products.
  • Negotiated with CMS to obtain new codes for medical devices under the Healthcare Common Procedure Coding System (HCPCS).
  • Petitioned FDA regarding the requirements for an Abbreviated New Drug Application that utilized a complex innovator drug product as the reference listed drug (RLD).